Instructions to Authors
Aims and Scope.
Molecular and Cellular Pharmacology publishes manuscripts in all areas broadly related to Pharmacological Sciences. Original Research Articles and Reviews will be considered for publication with the explicit understanding that such manuscripts have not been previously published or being considered for publication by another journal. It is preferred that manuscripts be submitted via the online submission system. If authors are unable to use the online submission system, they can email their manuscripts (in PDF format) to the editorial office.
Authors are advised to be succinct and avoid grammatical and typographical errors. Authors should also ensure that their manuscripts conform to the Journal guidelines. All Original Research Articles can be divided into the following sections:
The title should be informative and not too long. Full names and complete affiliations of all authors should be included. A running title, 6 keywords and name, full address including telephone number, and e-mail address of the corresponding author should also be provided.
The abstract should be succinct and of no more than 250 words.
Text should be divided into Introduction, Materials and Methods, Results and Discussion. Acknowledgments and information on ‘Conflicts of Interest’ should follow the ‘Discussion’ page.
References should be numbered consecutively in the order of their mention in the text. The Journal has adopted the guidelines of International Committee of Medical Journal Editors (ICMJE) on reference citations. More information can be found at (www.nlm.nih.gov/bsd/uniform_requirements.html), the National Library of Medicine and at (www.icmje.org), International Committee of Medical Journal Editors.
Journal articles should be cited as:
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
If more than six authors, list the first six and then et al. For example,
Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935:40-6.
Chapter in a book should be cited as:
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
An informative title for each table is required.
Figures should be numbered consecutively in the order of their mention in the text. It is authors’ responsibility to provide high-quality digital illustrations for clear reproduction; acceptable formats include TIFF, JPEG or PowerPoint. However, to expedite the peer-review process, authors can submit the entire manuscript in the PDF format for review-only.
A legend must be provided for each figure. Legends should be brief and informative.
The Journal will publish PharmSights in each issue. The Editors will invite authors of significant recent articles published in the Pharmacology literature to write overview of their published work. Authors will have the opportunity to provide additional insights into their published work and present results that were not included in their prior publication. Articles published as PharmSights will be by invitation only and undergo the standard peer-review process. There is no page limit and the Journal will not levy page charges on PharmSights, however, authors are advised to be succinct. The article can be divided into the following sections:
Abstract (no more than 250 words), Introduction, Materials and Methods (if any), Results and Discussion.
The Journal will publish comprehensive scholarly reviews in any area relevant to Pharmacological Sciences. Mini-reviews and ‘Literature Highlights’ on emerging topics are also encouraged. All ‘Review Articles’ are expected to also conform to the Journal guidelines and should have a Title page, an Abstract (250 words) and text. The text may be subdivided as deemed appropriate and supported by high-quality illustrations. The abbreviations should be defined at the time of their first use.
Molecular and Cellular Pharmacology has an international editorial board. When a manuscript is received, it is assigned to an editorial board member who will invite two or more external reviewers to evaluate the manuscript. The Journal endeavors to provide thorough evaluation of all manuscripts and editorial decisions are rendered in a timely manner. Revised Manuscripts. Authors should submit revised version of their manuscripts within three months following editorial decisions. Authors are advised that after 3 months, the revised version will be considered a new submission.
Molecular and Cellular Pharmacology, as an open access journal, allows ethical use and distribution of its published contents (by authors or third parties) for non-commercial purposes. Contents of the manuscripts published in Molecular and Cellular Pharmacology can be reused under Creative Commons License: CC BY-NC (https://creativecommons.org/licenses/by-nc/4.0/). Commercial use or distribution of Journal’s contents requires permission from the Journal. By submitting a manuscript for publication consideration in Molecular and Cellular Pharmacology, all authors accept the Journal’s policy as indicated above.
No Publication Charges.
Molecular and Cellular Pharmacology does not levy article processing charges (APCs) or page charges.
Although every effort is made to ensure accuracy of published work, the Journal (including its staff, editors, publishing service, publishers) does not take legal responsibility for any errors or omissions.